Healthcare -
Biotechnology - NASDAQ - US
$ 325.45
-1.31 %
$ 14.7 B
Market Cap
12.74
P/E
UTHR - OPERATING INCOME
Operating Income UTHR - United Therapeutics Corporation
1.38 B
LAST VALUE
18.56%
2 YEAR CAGR
56.34%
5 YEAR CAGR
9.84%
10 YEAR CAGR